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ABSTRACT
Objective: This study aims to evaluate the cardioprotective effect of fisetin on change in the activities of lysosomal enzymes in isoproterenol (ISO)-
induced myocardial infarction (MI) in male albino Wistar rats.
Methods: Rats were orally pretreated with fisetin (30 mg/kg body weight) daily for 30 days. After the pretreatment period, ISO (100 mg/kg body 
weight) was subcutaneously administered to rats at intervals of 24 h for 2 consecutive days.
Results: The activities of β-glucuronidase, β-N-acetylglucosaminidase, β-galactosidase, cathepsin-B, and cathepsin-D were significantly (*p<0.05) 
increased in serum and the heart of ISO-induced rats. Pre-treatment with fisetin daily for 30 days to ISO-induced rats significantly prevented these 
activities and restored their activities to near normal. Oral treatment with fisetin (30 mg/kg body weight) to normal control rats did not show any 
significant effect.
Conclusion: We have concluded that fisetin protects the β-glucuronidase, β-N-acetylglucosaminidase, β-galactosidase, cathepsin-B, and cathepsin-D 
against ISO-induced MI. The observed effects might be due to the free radical-scavenging and membrane-stabilizing effect of fisetin.
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INTRODUCTION
Cardiovascular disease remains one of the most deaths causing disease 
for both men and women [1]. Myocardial infarction (MI) makes an 
increase in contribution to mortality and morbidity statistics in 
developing countries due to their lifestyle changes mostly in urban 
areas [2]. MI occurs as a outcome of prolonged imbalance between 
coronary supply of blood and myocardial oxygen demand. It is well 
known that free radicals generated in ischemic tissues cause severe 
stresses, which result in degradation of tissue defense system, leading 
to cardiac damage [3]. Isoproterenol (ISO), a synthetic catecholamine 
and β-adrenergic agonist, causes severe stress in the myocardium, 
resulting in infarct-like necrosis of the heart tissue [4]. The model 
of ISO-induced cardiotoxicity is considered as most well-known 
experimental method [5]. ISO-induced myocardial necrosis involves 
changes in membrane permeability that brings myocardial membrane 
integrity and loss of function [6].
Recently, attention has been focused on phytochemicals and flavonoids, 
derived from different plant species as effective therapeutic agents in 
the management of cardiovascular disease due to their antioxidant 
nature [7]. Fisetin (Fig. 1) is a dietary phenolic flavonoid rich in 
strawberry, onion, persimmon, and cucumber. It has a wide variety of 
pharmacological activities such as antioxidant and anti-inflammatory 
activity mainly acting as a free radical scavenger. Fisetin is able to 
scavenge free radicals produced by ISO, as a result of its electron 
donating capacity, due to the presence of two hydroxyl groups on one 
ring and a hydroxyl group in another ring [8].
Lysosomes are membrane-bound structures that contain hydrolytic 
enzymes capable of degrading most of the cellular constituents. In 
addition, lysosomes play a major role in secretion and transport 
processes [9]. Lysosomal enzymes are the most important mediators 
of acute MI. Lysosomal hydrolases play a key role in the inflammatory 
process. ISO-induced MI results in increased lysosomal enzyme activity 
that may be responsible for heart tissue damage [10].
In the first phase of the experiment, we have observed the protective 
effect of fisetin on lipid peroxides, enzymic, and non-enzymic 
antioxidants in ISO-induced myocardial-infarcted rats [11]. However, 
any in vivo study on the protective effect of fisetin on lysosomal 
hydrolases has not been previously carried out. Therefore, the present 
investigation was undertaken to study the alterations in the activities 
of lysosomal enzymes and subcellular fractions during ISO-induced MI 




The experiments were carried out according to the guidelines of the 
committee and approved by the Institutional Animal Ethical Committee 
(IAEC/XLI/03/CLBMCP/2017). All the experiments were done with 
a healthy male albino Wistar rats, weighing 150–180 g. They were 
housed in polypropylene cages (47 cm×34 cm×20 cm) lined with husk, 
renewed every 24 h under a 12:12 h light dark cycle at around 22°C. 
The rats had free access to tap water and food.
Drug and chemicals
Fisetin and ISO hydrochloride were purchased from Sigma (St. Louis, 
MO, USA).
Induction of experimental MI
ISO (100 mg/kg) was dissolved in normal saline and subcutaneously 
injected to rats at an interval of 24 h for 2 days.
Experimental protocol
The animals were grouped into six rats in each group:
• Group I: Normal control rats received standard pelleted diet and 
orally administered with 0.5% dimethyl sulfoxide (DMSO) for 
30 days.
• Group II: Rats orally administered with fisetin (30 mg/kg body 
weight/day, dissolved in 0.5% DMSO) for 30 days.
© 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2019.v12i3.30974
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• Group III: Rats subcutaneously administered with ISO (100 mg/kg 
body weight/day) dissolved in physiological saline, for 2 days for the 
induction of MI.
• Group IV: Rats pretreated with fisetin (30 mg/kg body weight/day), 
for 30 days, before the induction of MI as described for Group III.
At the end of the experimental design period (i.e., 24 h after last injection 
of ISO), the control and experimental groups were sacrificed. Blood 
samples were collected and serum was separated by centrifugation.
Processing of heart sample
Heart tissues were removed and washed in physiological saline 
containing 0.8% sodium chloride. A tissue sample was homogenized in 
4.0ml 0.1M Tris-Hcl buffer (pH 7.4). The homogenate was centrifuged 
and the supernatant used for biochemical estimations.
Separation of subcellular fraction
The tissues were removed and the homogenate was used to 
ultracentrifugation, and the fractions were separated as follows: 
Structural proteins, nucleus, and cell debris at 6000 rpm for 10 min; 
mitochondria at 5000 rpm for 10 min; lysosomes at 15,000× g for 
10 min; microsomes at 120,000 rpm for 30 min; and supernatant, 
the cytosol. Subtractions were treated with Triton X-100 (final 
concentration of 0.3% v/v) for 20 min to the determination of enzymes 
activities [12].
Assay of lysosomal enzymes
The activities of β-glucuronidase, β-N-acetylglucosaminidase, and 
β-galactosidase were estimated by the methods of Kawai and Anno [13], 
Moore and Morris [14], and Conchie et al. [15], respectively. Activities 
of cathepsin-D and B were determined by the methods of Sapolsky 
et al. [16] and Barrett, [17] respectively. The content of protein was 
estimated by the method of Lowry et al. [18].
Statistical analysis
Statistical analysis was performed by one-way analysis of variance 
followed by Duncan’s multiple range test (DMRT) using Statistical 
Package for the Social Sciences software version 17.00. Data were 
expressed as mean±standard deviation for six rats in each group. 
*p<0.05 was considered to be statistically significant.
RESULTS
Table 1 shows the activities of β-glucuronidase, β-N-acetylglucosaminidase, 
β-galactosidase, and cathepsin-B and D in serum of control and 
experimental groups of rats. The activities of these enzymes were increased 
significantly (*p<0.05) in serum of ISO-induced rats when compared to 
normal control rats. Oral pre-treatment with fisetin (30 mg/kg) for 30 d 
significantly (*p<0.05) decreased the activities of enzymes in ISO-induced 
rats when compared to ISO alone treated rats groups.
Table 2 shows the activities of β-glucuronidase, β-N-acetylglucosaminidase, 
β-galactosidase, and cathepsin-B and D in the control heart and 
experimental groups of rats. The activities of these enzymes were 
significantly (*p<0.05) increased in the heart of ISO-induced rats when 
compared to normal control rats. Pre-treatment with fisetin (30 mg/kg) 
significantly (*p<0.05) decreased the activities of these enzymes in the 
heart of ISO-induced rats when compared to ISO alone induced rats.
Fig. 2 depicts the activity of β-glucuronidase in subcellular fractions 
of the heart in control and experimental groups of rats. The activity 
of β-glucuronidase was significantly (*p<0.05) decreased in nuclear, 
mitochondrial, lysosomal, and microsomal fractions of the heart in 
ISO-induced rats when compared to normal control rats. β-glucuronidase 
activity in cytosolic fraction was significantly (*p<0.05) increased in 
ISO-treated rats when compared to normal control rats. Pre-treatment Fig. 1: Structure of the fisetin
Table 1: Effect of fisetin on activities of β‑glucuronidase, β‑N‑acetylglucosaminidase, β‑galactosidase, and cathepsin‑B and D in serum of 









β-Glucuronidase (mmol of p-nitrophenol liberated/h/mg protein) 14.5±0.8a 14.7±0.9a 25.4±1.8b 16.6±0.8c
β-N-Acetylglucosaminidase (mmol of p-nitrophenol liberated/h/mg protein) 24.5±1.8a 25.2±1.9a 38.4±2.8b 29.6±2.0c
β-Galactosidase (mmol of p-nitrophenol liberated/h/mg protein) 19.5±0.8a 19.7±0.9a 29.4±1.8b 22.4±1.2c
Cathepsin-B (mmol of p-nitrophenol liberated/h/mg protein) 10.5±0.8a 10.7±0.8a 23.4±1.6b 17.6±0.7c
Cathepsin-D (mmol of tyrosine liberated/h/100 mg protein) 19.5±1.7a 19.9±1.8a 35.4±2.7b 26.6±2.1c
Each value is mean±SD for six rats in each group; values not sharing a common superscript (a, b, c,) differ significantly with each other (*p<0.05, DMRT). 
DMRT: Duncan’s Multiple Range Test, ISO: Isoproterenol, SD: Standard deviation
Table 2: Effect of fisetin on the activities of β‑glucuronidase, β‑N‑acetylglucosaminidase, β‑galactosidase, and cathepsin‑B and D in the 









β-Glucuronidase (mmol of p-nitrophenol liberated/h/mg protein) 24.5±1.7a 24.8±1.8a 43.4±2.8b 34.6±2.1c
β-N-Acetylglucosaminidase (mmol of p-nitrophenol liberated/h/mg protein) 29.3±1.8a 29.4±1.9a 53.4±3.8b 39.3±2.6c
β-Galactosidase (mmol of p-nitrophenol liberated/h/mg protein) 39.5±2.2a 39.8±2.3a 52.3±2.9b 45.4±2.6c
Cathepsin-B (mmol of p-nitrophenol liberated/h/mg protein) 20.5±2.1a 20.9±2.0a 43.4±2.6b 29.6±1.9c
Cathepsin-D (mmol of tyrosine liberated/h/100 mg protein) 19.9±1.8a 19.8±1.9a 28.2±2.7b 23.1±2.1c
Each value is mean±SD for six rats in each group; values not sharing a common superscript (a, b, c,) differ significantly with each other (*p<0.05, DMRT). 
DMRT: Duncan’s Multiple Range Test, ISO: Isoproterenol, SD: Standard deviation
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with fisetin (30 mg/kg) to ISO-induced rats significantly (*p<0.05) 
increased the activity of β-glucuronidase in nuclear, mitochondrial, 
lysosomal, and microsomal fractions of the heart and significantly 
(*p<0.05) decreased in the cytosolic fraction of the heart. ISO-induced 
groups showed an increased ratio of cytosol to bound lysosomal 
activities and cytosol to total activity for β-glucuronidase in the heart. 
Pre-treatment with fisetin (30 mg/kg) to ISO-induced rats showed a 
decreased ratio of cytosol to lysosomal and cytosol to total activities.
Fig. 3 depicts the activity of cathepsin-D in subcellular fractions in the 
heart of normal and ISO-induced rats. The activity of cathepsin-D was 
significantly (*p<0.05) lowered in nuclear, mitochondrial, lysosomal, 
and microsomal fractions in the heart of ISO-induced rats when 
compared to normal control rats. Cathepsin-D activity in cytosolic 
fraction of the tissues was significantly (p<0.05) increased in ISO-
treated rats when compared to normal control rats. Pre-treatment with 
fisetin (30 mg/kg) to ISO-induced rats significantly (*p<0.05) increased 
the activity of cathepsin-D in nuclear, mitochondrial, lysosomal, 
and microsomal fractions and significantly (p<0.05) decreased in 
the cytosolic fraction of the heart. ISO-induced rats also showed an 
increased ratio of cytosol to bound lysosomal activities and cytosol to 
total activity for cathepsin-D in the heart.
DISCUSSION
The present study indicated that fisetin significantly cardioprotected 
against ISO-induced oxidative stress (reactive oxygen species [ROS]) 
and MI in rats. The cardiac hypertrophy after administration of ISO is 
possibly due to the intramuscular water accumulation and the formation 
of interstitial fibrosis, as well as invasion by inflammatory cells [19]. The 
lysosomal compartment is one of the important sites of intracellular 
protein degradation. It contains several hydrolytic enzymes that can 
degrade closely all cellular components. Administration of ISO induced 
to rats leads to a significantly increase of lysosomal enzyme activities 
in the serum and myocardium. Intracellular release of lysosomal 
enzymes following myocardial ischemia resulted in cell death [20]. 
It has been proposed that oxygen free radicals generated during 
ischemia in addition to the direct myocardial damaging effect may 
also be responsible for the myocardial damage through the release of 
lysosomal enzymes [21]. Lysosomes are membrane-bound structures 
that play an important role in secretion. Lysosomal hydrolytic 
enzymes are involved in the degradation of cellular constituents. The 
intracellular release of lysosomal enzymes and their extralysosomal 
activity may play a major role in the progressive changes that lead from 
reversible myocardial injury to irreversible MI [22]. Elevated activities 
of β-glucuronidase, β-N-acetylglucosaminidase, β-galactosidase, and 
cathepsin-B and D were observed in the serum and heart of ISO-
treated rats. Fisetin could be maintaining the normal levels of their 
activities of heart tissues. Increased lipid peroxidation observed in ISO-
treated rats could have resulted in leakage of serum and myocardial 
acid hydrolases from the enclosed sacs due to lysosomal membrane 
damage [23]. It has been shown that the cytosolic acid hydrolases 
released from the sarcoplasmic reticulum and from lysosomes induce 
the dysfunction and destruction of mitochondria, sarcolemma, and 
other organelles [24]. Pre-treatment with fisetin normalized the 
activities of lysosomal enzymes both in the serum and myocardium by 
its inhibitory effect on lipid peroxidation, thereby preventing lysosomal 
damage induced by ISO-treated rats [25]. Cathepsins are lysosomal 
proteases possibly involved in autophagic digestion of cytoplasm 
and myofibrillary and mitochondrial proteins [26]. The activities of 
β-glucuronidase and cathepsin-D in different fractions except cytosolic 
fraction were decreased in ISO-induced rats. The decreased activity of 
these enzymes in different fractions clearly shows decreased stability 
of the membranes [27]. Fisetin pre-treatment inhibits the release of 
these enzymes from the lysosomal and microsomal fractions. Fisetin 
is due to the stabilizing effect on the lysosomal and microsomal 
membranes in ISO-induced rats. Our study also showed that fisetin 
inhibits the release of enzymes as well as decrease the activity of the 
total lysosomal hydrolases, thereby enhancing the lysosomal stability. 
Fisetin has effective scavenger of free radicals under in vivo conditions. 
Antioxidant activities are mainly due to its hydroxyl groups at C-3, C-3′, 
C-4′, and C-7 positions and are enriched by carbonyl group at C-4. The 
presence of double bond between C-2 and C-3 conjugated with the 
4-oxo group also eases higher electron delocalization. The potent free 
radical scavenging activity of fisetin was attributed to the presence of 
the C ring group. Fisetin acts as antioxidant properties by scavenging 
ROS and also improved the endogenous system in ISO-treated rats 
and suggested that the fisetin might be peroxides scavenging and/or 
due to blocking the peroxidation of membrane lipids. In this study, 
highlighting the fisetin preserves the lysosomal, mitochondrial, and 
cytosol membrane integrity in the serum, heart, and fractions of ISO-
induced rats.
CONCLUSION
The results of the present study indicated that the lysosomal hydrolases 
play an important role in ISO-induced MI and fisetin proved to be more 
protective in reducing the extent of lysosomal integrity in induced MI 
of rats.
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Fig. 2: Effect of fisetin on the activity of β‑glucuronidase in 
subcellular fractions of the heart in normal and experimental 
groups of rats. Each value is mean ± standard deviation for six 
rats in each group; values not sharing a common superscript 
(a, b, and c) differ significantly with each other (*p<0.05, 
Duncan’s Multiple Range Test)
Fig. 3: Effect of fisetin on the activity of cathepsin‑D in subcellular 
fractions of the heart in normal and experimental groups of 
rats. Each value is mean ± standard deviation for six rats in each 
group; values not sharing a common superscript (a, b, and c,) 
differ significantly with each other (p<0.05, Duncan’s Multiple 
Range Test)
519
Asian J Pharm Clin Res, Vol 12, Issue 3, 2019, 516-519
 Mythily and Devika 
REFERENCES
1. Aronow WS. Epidemiology, pathophysiology, prognosis, and treatment 
of systolic and diastolic heart failure. Cardiol Rev 2006;14:108-24.
2. Boudina S, Laclau MN, Tariosse L, Daret D, Gouverneur G, Bonoron-
Adèle S, et al. Alteration of mitochondrial function in a model of 
chronic ischemia in vivo in rat heart. Am J Physiol Heart Circ Physiol 
2002;282:H821-31.
3. Muruganandan S, Gupta S, Kataria M, Lal J, Gupta PK. Mangiferin 
protects the streptozotocin-induced oxidative damage to cardiac and 
renal tissues in rats. Toxicology 2002;176:165-73.
4. Jiang DJ, Tan GS, Ye F, Du YH, Xu KP, Li YJ, et al. Protective effects 
of xanthones against myocardial ischemia-reperfusion injury in rats. 
Acta Pharmacol Sin 2003;24:175-80.
5. Wexler BC. Myocardial infarction in young vs old male rats: 
Pathophysiologic changes. Am Heart J 1978;96:70-80.
6. Nirmala C, Puvanakrishnan R. Effect of curcumin on certain lysosomal 
hydrolases in isoproterenol-induced myocardial infarction in rats. 
Biochem Pharmacol 1996;51:47-51.
7. Dhawan S, Kapoor NK, Nityanand S. Effect of isoprenaline on lipid 
profile and cardiac enzymes in rats. Indian J Exp Biol 1978;16:376-8.
8. Banerjee SK, Maulik SK. Effect of garlic on cardiovascular disorders: 
A review. Nutr J 2002;1:4.
9. Decker RS, Poole AR, Griffin EE, Dingle JT, Wildenthal K. Altered 
distribution of lysosomal cathepsin D in ischemic myocardium. J Clin 
Invest 1977;59:911-21.
10. Ravichandran LV, Puvanakrishnan R, Joseph KT. Influence of 
isoproterenol-induced myocardial infarction on certain glycohydrolases 
and cathepsins in rats. Biochem Med Metab Biol 1991;45:6-15.
11. Mythily P, Devika PT. Cardioprotective effect of fisetin on lipid 
peroxide metabolism in isoproterenol induced myocardial infarction in 
male Wistar rats. Int J Innov Res Sci Eng Technol 2017;6:22306-14.
12. Sathish V, Ebenezar KK, Devaki T. Synergistic effect of nicorandil and 
amlodipine on lysosomal hydrolases during experimental myocardial 
infarction in rats. Biomed Pharmacother 2003;57:309-13.
13. Kawai Y, Anno K. Mucopolysaccharide-degrading enzymes from the 
liver of the squid, ommastrephes sloani pacificus. I. Hyaluronidase. 
Biochim Biophys Acta 1971;242:428-36.
14. Moore JC, Morris JE. A simple automated colorimetric method for 
determination of N-acetyl-beta-D-glucosaminidase. Ann Clin Biochem 
1982;19:157-9.
15. Conchie J, Gelman AL, Levvy GA. Inhibition of glycosidases by 
aldonolactones of corresponding configuration. The C-4- and C-6-specificity 
of beta-glucosidase and beta-galactosidase. Biochem J 1967;103:609-15.
16. Sapolsky AI, Altman RD, Howell DS. Cathepsin D activity in normal 
and osteoarthritic human cartilage. Fed Proc 1973;32:1489-93.
17. Barrett AJ. A new assay for cathepsin B1 and other thiol proteinases. 
Anal Biochem 1972;47:280-93.
18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement 
with the folin phenol reagent. J Biol Chem 1951;193:265-75.
19. Salah AR. Cardioprotective efficacy of taurine on lipid-metabolism of 
isoproterenol-induced myocardial infarction. Int J Pharm Pharm Sci 
2016;8:135-41.
20. Sudharsan PT, Mythili Y, Selvakumar E, Varalakshmi P. Lupeol and 
its ester ameliorate the cyclophosphamide provoked cardiac lysosomal 
damage studied in rat. Mol Cell Biochem 2006;282:23-9.
21. Garcia-Dorado D, Ruiz-Meana M. Propagation of cell death during 
myocardial reperfusion. News Physiol Sci 2000;15:326-30.
22. Kalra J, Prasad K. Oxygen free radicals and cardiac depression. Clin 
Biochem 1994;27:163-8.
23. Subashini R. Cardioprotective efficacy of Nelumbo nucifera Leaf 
extract on glycoprotein, membrane bound atpase and lysosomal 
enzymes against isoproterenol induced cardiotoxicity in Wistar rats. Int 
J Pharm Pharm Sci 2014;6:537-41.
24. Pillay CS, Elliott E, Dennison C. Endolysosomal proteolysis and its 
regulation. Biochem J 2002;363:417-29.
25. Devika PT, Prince PS. Preventive effect of (-)epigallocatechin-gallate 
(EGCG) on lysosomal enzymes in heart and subcellular fractions in 
isoproterenol-induced myocardial infarcted Wistar rats. Chem Biol 
Interact 2008;172:245-52.
26. Sano M, Takahashi Y, Yoshino K, Shimoi K, Nakamura Y, Tomita I, 
et al. Effect of tea (Camellia sinensis L.) on lipid peroxidation in rat 
liver and kidney: A comparison of green and black tea feeding. Biol 
Pharm Bull 1995;18:1006-8.
27. Ravens KG, Gudbjarnason S. Changes in the activities of lysosomal 
enzymes in infarcted canine heart muscle. Circ Res 1969;24:851-6.
